CND Life Sciences is pleased to announce the next webinar in our Tuesday Night Talks series. Todd Levine, MD, CND’s Co-Founder and Chief Medical Officer welcomes special guest Stuart H. Isaacson, MD, FAAN, Director of the Parkinson’s Disease and Movement Disorders Center of Boca Raton, FL to discuss the role and importance of alpha-synuclein as a key pathological marker.
The Syn-One Test® is the first in-office, cutaneous diagnostic tool that aids in the diagnosis of Parkinson’s disease, dementia with Lewy bodies, multiple system atrophy, pure autonomic failure, and REM sleep behavior disorder.
Join us on April 19 at 7:00 PM EST for this educational webinar and interactive Q&A session. Pre-register today.